Uptake Raises $3 Million Bridge Financing
Uptake Medical, a Seattle-based medical device company developing minimally invasive therapies for emphysema and COPD, has raised $3 million in bridge financing. Uptake’s lead product is a bronchoscopic catheter for delivering vapor to emphysematous lung regions.
According to the company, applying energy to emphysematous lung regions scars down those regions allowing better functioning lung regions to expand thus offering patients improved overall breathing mechanics. Uptakes dubs its technology Bronchoscopic Thermal Vapor Ablation or (BTVA) for short.